Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia

NCT04318977 is registered in ClinicalTrials.gov with University of Regensburg as lead sponsor.

NCT NCT04318977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04318977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia
Lead sponsor
University of Regensburg
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 1, 2020
Completion date
December 30, 2025
Enrollment
62 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

negative symptoms with primary psychotic disorder, schizophrenia